- Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002Roger Bedimo
University of Alabama at Birmingham, USA
Clin Infect Dis 39:1380-4. 2004..87; P<.0002). The mean CD4 cell count was lower among patients with ADMs than among those with non-ADMs. A longer duration of survival during highly active antiretroviral therapy might explain the increasing incidence of non-ADMs...
- Sustained HIV viral suppression following treatment interruption: an observational studyRoger Bedimo
University of Alabama, Birmingham, Alabama 85294, USA
AIDS Res Hum Retroviruses 22:40-4. 2006..Examining the immune responses of nonrebounders may contribute to the understanding of protective immunity to HIV...
- Lipid abnormalities in HIV/hepatitis C virus-coinfected patientsR Bedimo
Department of Medicine, Division of Infectious Diseases, University of Texas South western Medical Center at Dallas, Dallas, TX 75216, USA
HIV Med 7:530-6. 2006..Among HIV-infected patients, hepatitis C virus (HCV) coinfection is associated with increased rates of lipodystrophy and insulin resistance. Its impact on HIV-associated dyslipidaemia is less clear...
- Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy eraRoger J Bedimo
VA North Texas Health Care System, University of Texas Southwestern Medical Center, Dallas, Texas 75216, USA
Clin Infect Dis 53:84-91. 2011..Some studies have suggested that exposure to antiretroviral therapy (ART) with abacavir is associated with an increased risk of acute myocardial infarction (AMI)...
- Predictive value of HIV-1 replication capacity and phenotypic susceptibility scores in antiretroviral treatment-experienced patientsR Bedimo
Veterans Affairs North Texas Health Care System, Dallas, TX 75216, USA
HIV Med 13:345-51. 2012..The aim of the study was to determine the prognostic value of HIV replication capacity (RC) for subsequent antiretroviral (ARV) treatment response in ARV-experienced patients...
- Hepatitis C virus coinfection and the risk of cardiovascular disease among HIV-infected patientsR Bedimo
Department of Medicine, VA North Texas Health Care System, Dallas, 75216, USA
HIV Med 11:462-8. 2010..Among HIV-infected patients, hepatitis C virus (HCV) coinfection is associated with lower cholesterol levels, but it remains unclear how it affects cardiovascular outcomes...
- Lipid-lowering efficacy and safety after switching to atazanavir-ritonavir-based highly active antiretroviral therapy in patients with human immunodeficiency virusSean T Nguyen
Texas Tech University Health Sciences Center School of Pharmacy, Dallas Fort Worth Regional Campus, Dallas, Texas 75216, USA
Pharmacotherapy 28:323-30. 2008....
- Safety and efficacy of simvastatin for the treatment of dyslipidemia in human immunodeficiency virus-infected patients receiving efavirenz-based highly active antiretroviral therapyAnita P Rahman
School of Pharmacy, Texas Tech University Health Sciences Center, Dallas Fort Worth Regional Campus, Dallas, Texas 75216, USA
Pharmacotherapy 28:913-9. 2008....
- Non-AIDS-defining malignancies among HIV-infected patients in the highly active antiretroviral therapy eraRoger Bedimo
VA North Texas Health Care System and University of Texas Southwestern Medical Center, 4500 South Lancaster Road, Dallas, TX 75216, USA
Curr HIV/AIDS Rep 5:140-9. 2008....
- Improvement in insulin sensitivity and dyslipidemia in protease inhibitor-treated adult male patients after switch to atazanavir/ritonavirAnthony J Busti
Texas Tech University Health Sciences Center School of Pharmacy, Dallas, Texas, USA
J Investig Med 56:539-44. 2008..However, its effects on insulin sensitivity have not been elucidated. We conducted this study to test the hypothesis that ATV improves insulin resistance and dyslipidemia...
- The management of musculoskeletal infection in HIV carriersJean Bahebeck
University Hospitals of Yaoundé, Cameroon
Acta Orthop Belg 70:355-60. 2004..For those who are MID, the indication for antiretroviral therapy should depend on the presence of one or more AIDS-related signs...